Screener
Ocular Therapeutix OCUL Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Total costs and operating expenses | 104,125 | 74,615 |
| Loss from operations | (93,340) | (63,917) |
| Other income (expense): | ||
| Interest income | 6,050 | 3,826 |
| Interest expense | (2,777) | (2,984) |
| Change in fair value of derivative liabilities | 1,455 | (978) |
| Total other income (expense), net | 4,728 | (136) |
| Net loss | $(88,612) | $(64,053) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's interest income?
- Ocular Therapeutix (OCUL) reported interest income of $6.05M in Q1 2026.
- How has Ocular Therapeutix's interest income changed year-over-year?
- Ocular Therapeutix's interest income increased by 58.1% year-over-year, from $3.83M to $6.05M.
- What is the long-term trend for Ocular Therapeutix's interest income?
- Over 4 years (2021 to 2025), Ocular Therapeutix's interest income has grown at a 385.6% compound annual growth rate (CAGR), from $33K to $18.35M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Ocular Therapeutix's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude